What changed
$MDLZ — ADD 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $10.1B | EPS $0.67 vs $0.61 🟢 | Margin 11.4%
💡 Consensus expected $0.61 EPS, but MDLZ delivered $0.67. The market may be pricing in stagnant growth and margin pressure, yet the beat suggests improving volumes and cost control. Current trailing PE of 29.8x is below the historical range of 30.0-31.5x, implying overly pessimistic sentiment relative to the earnings trajectory.
📉 Reward/risk: 2.0:1
🏢 Business Quality: 7/10 - Global snacking leader with iconic brands and defensive demand, but mature category and exposure to input cost volatility limit upside.
📊 Valuation: cheap vs own history (trailing PE 29.8x vs median 30.7x and range 30.0-31.5x); fair on absolute basis (forward P/E ~22.5x, EV/EBITDA ~15-17x, in line...
📊 Our read: ADD. Full analysis →
https://stockduty.xyz/s/MDLZ0621